Background Cervical cancer screening coverage is a key monitoring indicator of the WHO
cervical cancer elimination plan. We present global, regional, and national cervical …

Cancer is currently the first or second most common contributor to premature mortality in
most countries of the world. The global number of patients with cancer is expected to rise …

Background Tracking progress and providing timely evidence is a fundamental step forward
for countries to remain aligned with the targets set by WHO to eliminate cervical cancer as a …

This WHO and HRP guideline is designed to help countries make faster progress, more
equitably, on the screening and treatment of cervical cancer. It includes some important …

Summary Background The WHO Director-General has issued a call for action to eliminate
cervical cancer as a public health problem. To help inform global efforts, we modelled …

Page 1 GLOBAL STRATEGY TO ACCELERATE THE ELIMINATION OF CERVICAL CANCER
AS A PUBLIC HEALTH PROBLEM Global strategy to accelerate the elimination of cervical …

This article provides an update on the global cancer burden using the GLOBOCAN 2020
estimates of cancer incidence and mortality produced by the International Agency for …

As a promising alternative platform for cellular immunotherapy, natural killer cells (NK) have
recently gained attention as an important type of innate immune regulatory cell. NK cells can …

An increasing body of evidence supports the validity of self-sampling as an alternative to
clinician collection for primary Human Papillomavirus (HPV) screening. Self-sampling …

Human papillomavirus (HPV) vaccines, which were introduced in many countries in the past
decade, have shown promising results in decreasing HPV infection and related diseases …